ULURU, Inc. is a pharmaceutical company, which engages in the development and commercialization of wound care and muco-adhesive film products. The Altrazeal technology is a new class of material designed to optimize the wound bed environment and accelerate healing. The OraDisc technology is a water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. The company was founded on September 17, 1987 and is headquartered in Addison, TX.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company